Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: This systematic review and meta-analysis aimed to investigate the relationship between statin consumption and risk of incidence of ovarian cancer (OC) and associated mortality.
Methods: Computerized searches were conducted in three electronic databases (PubMed, Web of Science, and Scopus). Two calibrated authors performed the publications selection, data extraction, and quality assessment of the selected publications. The quality of the included articles was evaluated using the Newcastle-Ottawa Scale (NOS) for observational studies, and Jadad criteria for randomized clinical trials (RCTs). The electronic searches retrieved 2272 titles/abstracts. After the deletion of duplicate publications, 2030 titles/abstracts were assessed. Eighteen articles were included.
Results: Meta-analysis demonstrated that risk ratio (RR) of the association between statin consumption and OC incidence was 0.88 (95% CI = 0.75-1.03, P = 0.109). Patients receiving statin were less likely to die than those who did not receive statin, with a statistically significant association [RR = 0.76 (95% CI 0.67-0.86, P = 0.0001)]. There was no evidence of publication bias in examining the association between statin consumption and the risk of incidence and mortality from OC.
Conclusions: This study determined that statin use reduced the incidence risk of OC and significantly increased the survival in OC patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595068 | PMC |
| http://dx.doi.org/10.15167/2421-4248/jpmh2020.61.3.1497 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy, safety and cost-effectiveness of 40 mg versus 80 mg atorvastatin in a Sri Lankan cohort with acute coronary syndrome: a protocol for a single-centre randomised controlled clinical trial.
Trials
September 2025
Department of Pharmacology, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka.
Background: Most guidelines recommend high-intensity statins for the secondary prevention of acute coronary syndrome (ACS). However, several studies from other Asian populations suggest enhanced sensitivity to statins, with effective low-density lipoprotein cholesterol (LDL-C) reduction seen at lower doses and possible higher incidence of adverse effects at higher statin doses. However, there is no published data from Sri Lanka.
View Article and Find Full Text PDFMedication Adherence and Hospital Readmissions: A Cross-Sectional Analysis of Medicare Star Ratings Performance.
J Am Pharm Assoc (2003)
August 2025
HEOR Strategic Planning, MMS, Becton, Dickinson and Company, Franklin Lakes, NJ, USA. Electronic address:
Background: The Medicare Star Ratings program, administered by the Centers for Medicare & Medicaid Services, includes a list of quality measures aimed at evaluating the quality of care provided by Medicare health plans. These measures include three medication adherence measures (non-insulin antidiabetics, renin-angiotensin system antagonists (RASA), and statins), as well as a plan all-cause readmission (PACR) measure, among dozens of other measures.
Objective: To examine the potential association between the three Medicare Star Rating medication adherence measures and the PACR measure.
Red yeast rice with monacolin K for the improvement of hyperlipidemia: A narrative review.
World J Clin Cases
September 2025
Department of Internal Medicine, University of Nebraska Medical Center College of Medicine, Omaha, NE 68198, United States.
Low-density lipoprotein cholesterol (LDL-C) is the most causal risk factor for atherosclerotic cardiovascular disease (ASCVD). Red yeast rice (RYR) is a nutraceutical widely used as a lipid-lowering dietary supplement. The main cholesterol-lower agents in RYR are monacolins, particularly monacolin K, a weak reversible inhibitor of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, whose daily consumption (up to 10 mg/day) reduces LDL-C plasma levels up to 34% within 6-8 weeks when compared to placebo.
View Article and Find Full Text PDFBackground: Coronary artery calcium scoring (CACS) by computed tomography could enhance risk assessment and decision making for preventive medication in patients with diabetes. We performed a microsimulation study to compare costs and health outcomes of guideline-based periodic cardiovascular risk assessment with and without CACS.
Methods: We modeled various US guideline-based preventive approaches based on periodically assessed 10-year risk by pooled cohort equations with and without CACS.
Assessment of the Utilization of Lipoprotein (a) and its Relationship with Cardiovascular Outcomes: A Retrospective Cohort Study from a Public Hospital in New York City.
Heart Views
July 2025
Department of Medicine, Jacobi Medical Center, New York City Health and Hospitals Corporation, Bronx, NY, USA.
Introduction: Lipoprotein (a) [Lp(a)] is an independent genetic risk factor for atherosclerotic cardiovascular disease (ASCVD) and is associated with an increased risk of heart failure (HF), multiple vascular and valvular abnormalities and is closely linked to various lipid components, particularly low-density lipoprotein (LDL) cholesterol. Despite its clinical significance, Lp(a) testing has not gained widespread use in healthcare practice. Our study aimed to assess the utilization of Lp(a) testing and its association with ASCVD risk factors, HF phenotypes, vascular and valvular pathologies, lipid profiles, and the use of lipid-lowering drugs at a safety-net hospital within the largest municipal healthcare system in the United States.
View Article and Find Full Text PDF